IL249402A0 - Aminoglycosides for the treatment of Rett's syndrome - Google Patents

Aminoglycosides for the treatment of Rett's syndrome

Info

Publication number
IL249402A0
IL249402A0 IL249402A IL24940216A IL249402A0 IL 249402 A0 IL249402 A0 IL 249402A0 IL 249402 A IL249402 A IL 249402A IL 24940216 A IL24940216 A IL 24940216A IL 249402 A0 IL249402 A0 IL 249402A0
Authority
IL
Israel
Prior art keywords
treatment
rett syndrome
aminoglycoside analogs
aminoglycoside
analogs
Prior art date
Application number
IL249402A
Other languages
English (en)
Hebrew (he)
Inventor
Pelled Dori
Tuvia Shmuel
Baasov Timor
Original Assignee
Pelled Dori
Tuvia Shmuel
Baasov Timor
Eloxx Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pelled Dori, Tuvia Shmuel, Baasov Timor, Eloxx Pharmaceuticals Ltd filed Critical Pelled Dori
Publication of IL249402A0 publication Critical patent/IL249402A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL249402A 2014-06-05 2016-12-05 Aminoglycosides for the treatment of Rett's syndrome IL249402A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462008028P 2014-06-05 2014-06-05
PCT/IL2015/050573 WO2015186134A1 (en) 2014-06-05 2015-06-04 Use of aminoglycoside analogs in the treatment of rett syndrome

Publications (1)

Publication Number Publication Date
IL249402A0 true IL249402A0 (en) 2017-02-28

Family

ID=53525222

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249402A IL249402A0 (en) 2014-06-05 2016-12-05 Aminoglycosides for the treatment of Rett's syndrome

Country Status (6)

Country Link
US (2) US20170360817A1 (enExample)
EP (1) EP3151840A1 (enExample)
JP (1) JP2017516835A (enExample)
CA (1) CA2949754A1 (enExample)
IL (1) IL249402A0 (enExample)
WO (1) WO2015186134A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2640734T1 (en) 2010-11-18 2018-02-28 Technion Research & Development Foundation Ltd. Aminoglycosides and their uses in the treatment of genetic disorders
JP2017516835A (ja) 2014-06-05 2017-06-22 エロックス ファーマシューティカルズ リミテッド レット症候群治療におけるアミノグリコシド類縁体の使用
EP3344641A4 (en) * 2015-09-02 2019-09-18 Eloxx Pharmaceuticals Ltd. AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES
US11306115B2 (en) 2015-09-02 2022-04-19 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
EP3350194A4 (en) 2015-09-02 2019-04-24 Eloxx Pharmaceuticals Ltd. AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES
CN117466958A (zh) * 2017-03-15 2024-01-30 Eloxx制药有限公司 假三糖氨基糖苷及其中间体的大规模制备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5960712A (ja) 1982-09-30 1984-04-06 Toshiba Corp デ−タ判別装置
WO2005078099A1 (en) * 2004-02-17 2005-08-25 The Hospital For Sick Children Mecp2e1 gene
EP2390255B1 (en) 2006-04-03 2016-07-13 Technion Research & Development Foundation Ltd. Novel aminoglycosides and uses thereof in the treatment of genetic disorders
SI2640734T1 (en) * 2010-11-18 2018-02-28 Technion Research & Development Foundation Ltd. Aminoglycosides and their uses in the treatment of genetic disorders
JP2017516835A (ja) 2014-06-05 2017-06-22 エロックス ファーマシューティカルズ リミテッド レット症候群治療におけるアミノグリコシド類縁体の使用

Also Published As

Publication number Publication date
WO2015186134A1 (en) 2015-12-10
JP2017516835A (ja) 2017-06-22
US20170360817A1 (en) 2017-12-21
EP3151840A1 (en) 2017-04-12
US20190183915A1 (en) 2019-06-20
CA2949754A1 (en) 2015-12-10
US10576095B2 (en) 2020-03-03

Similar Documents

Publication Publication Date Title
IL250685A0 (en) Medicinal substance induces cytotoxicity
PL3132034T3 (pl) Środek terapeutyczny
IL247072A0 (en) Medical use
GB201403093D0 (en) Therapeutic compounds and their use
IL250387A0 (en) combined treatment
IL251371A0 (en) Cortexolone 17alpha-benzoate for use in the treatment of tumors
GB201405033D0 (en) Combination therapy
EP3190886C0 (en) COMPOSITIONS FOR USE IN THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME
ZA201702522B (en) Combination therapy
IL249402A0 (en) Aminoglycosides for the treatment of Rett's syndrome
GB201410216D0 (en) Therapeutic
GB201502412D0 (en) Therapeutic use
IL251350A0 (en) Treatment of Rett syndrome
GB201510637D0 (en) Therapeutic
SG11201607717QA (en) Therapeutic instrument
SI3397270T1 (sl) Sestavki za uporabo pri zdravljenju hunterjevega sindroma
ZA201608217B (en) Combination therapy
GB201506786D0 (en) Therapeutic use
GB201406115D0 (en) New pharmaceutical use
GB201513543D0 (en) Compositions for use in the treatment of diabetes
GB201408233D0 (en) Use of polyanionic composition
GB201409662D0 (en) New pharmaceutical use
GB201410334D0 (en) Therapeutic
ZA201408464B (en) Composition for the use in treatment of asthma
GB201404391D0 (en) Novel compositions having use in therapy